Amreen Khan
Indian Institute of Technology Bombay: Mumbai, Maharashtra , IN, Biocon Biologics Ltd, Indian Institute of Technology Bombay
About
Amreen Khan completed her Ph.D. program working in biomedical applications of cancer theranostics nanomedicine and wound healing at the Indian Institute of Technology Bombay India. Till now she has contributed to 5+ publications, book chapters, patents and mentored 5+ master and bachelor trainees. Adding to her credits she has won best poster presentation awards and excellent recognition for oral presentation at international conferences in the past couple of years. She has been awarded the Young Researcher Award by the word cancer congress (2021) and drug discovery and development (2021). She has also received nominated from the inspirational women list in STEM by RBTC. Amreen believes in sharing knowledge and has worked with different NGOs to educate underprivileged children and aspiring students for competitive exams.
Employment
-
Biocon Biologics Ltd Executive2015 - 2017
-
Indian Institute of Technology Bombay: Mumbai, Maharashtra , IN Postdoctoral Fellow
Education
-
Indian Institute of Technology Bombay PhD2018 - Present
Projects & Funding
Projects & funding information is unavailable.
Publications (18)
- Impact of Stimuli-Responsive Biomaterials in Gynecological Cancer Therapy Save
- Development of injectable upconversion nanoparticle-conjugated doxorubicin theranostics electrospun nanostructure for targeted photochemotherapy in breast cancer Save
- Surrogate Gradient-Based Medical Image Classification Using Spike Neural Network Save
- Synthesis and screening for anticancer activity of two novel telluro-amino acids: 1,3-Tellurazolidine-4-carboxylic acid and tellurohomocystine Save
- Solid Lipid Nanoparticles: Towards Emerging Cancer Nanomedicine Save
- Self-Assembled Nanostructures Save
- Nanoherbal gel formulations and delivery strategies Save
- Hypoxia-targeting drugs as new cancer chemotherapy agents: Molecular insights Save
- Screening of AS101 analog, organotellurolate (IV) compound 2 for its in vitro biocompatibility, anticancer, and antibacterial activities Save
- Solid Lipid Nanoparticles Save